设计基于1,4-二二的多目标疗法:最近的进展和未来的方向
Aditi Soni1,2, Monika Sharma1,3, Rajesh K Singh1
1Department of Pharmaceutical Chemistry, Shivalik College of Pharmacy, Nangal, District Ropar, Punjab 140124, India.
Current topics in medicinal chemistry
|May 6, 2025
概括
1,4-二二胺 (1,4-DHPs) 是多功能支架,具有多种治疗潜力. 优化它们的结构-活性关系 (SAR) 是开发用于复杂疾病的强效选择性药物的关键.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 1,4-二氧化 (1,4-DHPs) 是多功能支架,具有已证明的抗癌,心血管,抗氧化,抗炎,抗微生物和止痛作用.
- 结构性修改显著影响1,4-DHPs的结合亲和力,生物可用性和选择性.
研究的目的:
- 通过分析生物活动和结构-活性关系 (SAR) 来审查1,4-DHPs的治疗潜力.
- 为优化1,4-DHPs的药理疗效提供对结构修改的见解.
主要方法:
- 在PubMed,ScienceDirect,Elsevier和谷歌学者 (过去十年) 的综合文献搜索.
- 包括对1,4-DHP药理性质,SAR和治疗潜力的同行评审研究.
- 数据提取的重点是SAR趋势和结构修改的影响.
主要成果:
- 芳香替代剂,基和异环环的特定修饰增强了1,4-DHP的生物活性和选择性.
- 1,4-DHPs调节关键酶和受体,作为有效的多目标剂.
- 对比SAR分析支持1,4-DHPs作为下一代治疗药物的潜力.
结论:
- 1,4-DHPs代表了开发针对复杂多因素疾病的药物的有希望的框架.
- 优化SAR允许设计更有选择性和更强效的基于1,4-DHP的药物.
- 未来的研究应该专注于改进结构修改,以最大限度地发挥治疗潜力.
关键词:
1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 1 2 2 1 1 1 1 1 1 1 1 1 2 2 1 1 1 1 1 1 1 1 1 1 2 2 1 1 1 1 1 1 1 2 2 1 1 1 1 1 1 1 1 2 2 2 1 1 1 1 1 1 2 2 1 1 1 1 1 1 1 1 1 2 2 2 1 1 1 1 1 2 2 1 1 1 1 1 1 1 2 2 2 1 1 1 1 1 1 1 1 2 2 1 1 1 1 1 1 2 2 1 1 1 1 2 1 1 1 1 2 1 1 1 1 1 1 1 1 2 1 1 1 2 1 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 known known known known known known known known known known known known known4-DHP) 的使用.4-二二氨酸 (1-二二氨酸)止痛药是一种止痛药.这是一种抗炎药物.这是一种抗癌药物.抗微生物药物是一种抗菌药物.抗氧化剂是一种抗氧化剂.心血管保护 保护心血管药物耐药性 耐药性 药物耐药性结构-活动关系 (SAR).更多相关视频
09:44Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
10.0K
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.2K
相关概念视频
01:26Targets for Drug Action: Overview
5.8K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
5.8K
01:28Structure-Activity Relationships and Drug Design
420
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
420
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:24Principles of Drug Action
5.6K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.6K
01:26Drug Discovery: Overview
7.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.1K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K